This webinar presentation focuses on leveraging AI and data analytics to address challenges in clinical trial feasibility, particularly for rare disease trials.
Gain insights from Rohit Nambisan, of Lokavant, Otis Johnson, with Trial Equity, Mohammed Ali, from Astellas Pharma and Michelle Everill former BMS. Their key discussions are focused on improving patient enrollment, optimizing trial design using advanced data and analytical tools and increasing diversity in clinical trials for ethical and practical benefits, including efficiency. The future of trial feasibility looks promising with AI and data-driven strategies. Listen in to learn more from these industry experts!
